Gender Pain Gap
Based on pre-clinical and clinical studies confirming the safety and efficacy of CBD.
50% to 90% of menstruators have dysmenorrhea i.e., severe and frequent period pain which goes socially and culturally dismissed as normal.
Here’s how AIMA takes care of menstural pain:
Based on pre-clinical and clinical studies confirming the safety and efficacy of CBD.
Enables menstruators to continue daily and physical activities with comfort.
Established in 2019 in Vancouver, British Columbia, Canada AIMA Inc. is founded, led, and supported by industry experts and intersectional feminists.
Lanna is a queer ecofeminist and advocate for gynaecological health. She started AIMA (eh-ma) in 2019 as a response to a lack of safe solutions for her period pain, and Aruna Revolution in 2021 to address menstrual waste. She continues to disrupt the system of inequities through her unruly work and writing.
Melanie is a parachuting accident survivor and former chronic pain NSAID user. She is an experienced lab technician in drug delivery, stem cells, & genetic engineering and has start-up experience in biotech and eCommerce. She is leading the operations and finance at AIMA.
Mali is a scientific and technical expert in drug discovery and delivery, leading the R&D and bringing industry experience through her work at AstraZeneca Canada. Her prior research focused on designing fast-acting and long-lasting drug delivery systems to be used topically or on the mucosal membranes.
Ovy is Aima’s first product in line to provide safe, effective, and localized pain relief, with dosages personalized based on pain and response level.